Medpage Today on MSN2d
Real-World Data on the RSV Vaccine for Older Adults
Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...
Medpage Today on MSN2d
Which High-Risk Patients Should Get the RSV Vaccine?
The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...
Glamour on MSN3d
The RSV Vaccine for Infants: Everything Parents Need to Know
The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...
中国日报网1d
First bivalent mRNA vaccine candidate against RSV goes under clinical trial
The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...
Study reveals best timing for getting the RSV vaccine during pregnancy to protect newborns
Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically ...
GlobalData on MSN8d
GSK’s RSV vaccine approved in Canada for adults aged 50 to 59
GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.
News Medical on MSN6d
Volunteers needed for trial of newly developed vaccine candidate for respiratory diseases
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Sierra Sun Times2d
UC San Francisco on New RSV Vaccine and Updated Vaccine Guidance for Seniors
Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...
Armed robbery in Revesby6d
Volunteers Sought for New Respiratory Vaccine Trial
Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's ...
News Medical on MSN2d
Early RSV vaccination in pregnancy provides best protection for newborns
Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for ...
Daily3d
GSK RSV vaccine approved in Canada for adults aged 50-59 at increased risk
Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...